What is the role of Citralka (disodium hydrogen citrate) in the management of urinary tract infection (UTI)?

Citralka (Disodium Hydrogen Citrate) Has No Established Role in UTI Treatment

Citralka is NOT recommended for the treatment of urinary tract infections. The most recent and highest quality evidence—the 2024 European Association of Urology Guidelines—does not include urinary alkalinization or citrate preparations in any treatment recommendations for UTI 1.

Why Citralka Is Not Part of Standard UTI Management

What Current Guidelines Actually Recommend

The 2024 EAU guidelines provide clear, evidence-based treatment algorithms for all UTI types 1:

For uncomplicated cystitis:

• Antimicrobial therapy based on local resistance patterns
• Symptomatic therapy (e.g., ibuprofen) may be considered as an alternative in mild cases

For complicated UTIs:

• Combination therapy: Amoxicillin plus aminoglycoside, OR second-generation cephalosporin plus aminoglycoside, OR IV third-generation cephalosporin
• Treatment duration: 7-14 days depending on clinical factors
• Mandatory management of underlying urological abnormalities

Notably absent: Any mention of urinary alkalinizers, citrate preparations, or pH modification as therapeutic interventions.

The Limited Historical Evidence

While older studies from the 1980s examined sodium citrate for symptomatic relief 2, 3, these findings are outdated and superseded by modern evidence:

• A 1984 study showed sodium citrate provided symptomatic relief in 80% of women with presumed non-bacterial cystitis 2
• However, this approach failed to address actual bacterial infections and is not aligned with current antimicrobial stewardship principles
• The 2024 guidelines make no reference to this approach, effectively rendering it obsolete

Critical Distinction: Citrate for Stones vs. UTI

Important caveat: Potassium citrate (not disodium hydrogen citrate/Citralka) has an established role in preventing kidney stones, not treating UTI 4, 5. This is a completely different indication and should not be confused with UTI management.

What Actually Works: Evidence-Based UTI Management

The Core Principles (2024 Guidelines)

1. Appropriate antimicrobial selection based on:

   • Severity of illness
   • Local resistance patterns
   • Patient-specific risk factors
   • Urine culture and susceptibility results 1

2. Address underlying factors:

   • Obstruction
   • Foreign bodies
   • Incomplete voiding
   • Immunosuppression 1

3. Antimicrobial stewardship:

   • Avoid treating asymptomatic bacteriuria (except in pregnancy and before urological procedures) 1
   • Use targeted therapy once culture results available 6

When Citralka Might Be Contraindicated

Potassium citrate preparations are actually contraindicated in UTI according to therapeutic literature 5, likely because:

• Alkalinization may reduce efficacy of certain antibiotics
• Does not address the underlying bacterial infection
• May promote growth of urease-producing organisms in complicated cases

Bottom Line for Clinical Practice

Do not prescribe Citralka for UTI. Instead:

• For uncomplicated cystitis: Use appropriate antibiotics (fluoroquinolones if local resistance <10%, nitrofurantoin, or fosfomycin) or consider symptomatic therapy alone in mild cases
• For complicated UTI: Use combination IV therapy initially, obtain cultures, and address underlying urological abnormalities 1
• For recurrent UTI: Focus on identifying and correcting predisposing factors, not urinary alkalinization

The absence of citrate/alkalinization therapy from the 2024 EAU guidelines 1 and the 2025 IDSA guidelines 6 represents the current standard of care based on morbidity and mortality outcomes.